IFNG and plasma cell myeloma: Inspired by the computational analyses indicating the presence of an IFN regulatory factor binding site, we evaluated the IFNγ-responsiveness of the novel promoter in the murine fibroblastic cell line NIH 3T3, the murine myeloma cells line MPC11, and the murine osteoblastic cell line MC3T3, respectively (Figure 6A).